![]() |
Link a Tocris |
![]() |
Información esencial Tocris |
![]() |
Posters y Guias Tocris |
![]() |
Infromación Gnral Reactivos |
Empresa de biotecnología con sede en Houston, cerca del Centro Médico de Texas, centrada en I+D, fabricación y comercialización de Proteínas, Anticuerpos y Kits de Inmunoensayo de altísima calidad.
TNFSF15; TL1; VEGI; VEGI192A; Tumor Necrosis Factor(ligand)Superfamily,Member 15; TNF Superfamily Ligand TL1A; TNF Ligand-Related Molecule 1; Vascular Endothelial Growth Inhibitor
TRAP; TRAP3; E3 ubiquitin-protein ligase TRAF2; Tumor necrosis factor type 2 receptor-associated protein 3
TRAP; TRAP3; E3 ubiquitin-protein ligase TRAF2; Tumor necrosis factor type 2 receptor-associated protein 3
LAP1; CAP-1; CD40bp; CRAF1; CD40 receptor-associated factor 1; CD40-binding protein; LMP1-associated protein 1
LAP1; CAP-1; CD40bp; CRAF1; CD40 receptor-associated factor 1; CD40-binding protein; LMP1-associated protein 1
CART1; MLN62; RNF83; Cysteine-rich domain associated with RING and Traf domains protein 1; Metastatic lymph node gene 62 protein; RING finger protein 83
CART1; MLN62; RNF83; Cysteine-rich domain associated with RING and Traf domains protein 1; Metastatic lymph node gene 62 protein; RING finger protein 83